Literature DB >> 22065139

(E)-4-Phenyl-butan-2-one oxime.

Hoong-Kun Fun, Wan-Sin Loh, Reshma Kayarmar, G K Nagaraja.   

Abstract

In the title compound, C(10)H(13)NO, the C-C-C-C torsion angle formed between the benzene ring and the butan-2-one oxime unit is 73.7 (2)°, with the latter lying above the plane through the benzene ring. In the crystal, inter-molecular O-H⋯N hydrogen bonds link pairs of mol-ecules into dimers, forming R(2) (2)(6) ring motifs which are stacked along the a axis.

Entities:  

Year:  2011        PMID: 22065139      PMCID: PMC3200599          DOI: 10.1107/S1600536811031928

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For background to oximes and their microbial activity, see: El-Sabbagh et al. (1990 ▶); El-Sayed et al. (1996 ▶); Althuis et al. (1979 ▶); Nargund et al. (1992 ▶); Srivastava et al. (2004 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C10H13NO M = 163.21 Monoclinic, a = 5.450 (3) Å b = 9.698 (6) Å c = 18.455 (12) Å β = 93.888 (13)° V = 973.1 (11) Å3 Z = 4 Mo Kα radiation μ = 0.07 mm−1 T = 297 K 0.67 × 0.15 × 0.12 mm

Data collection

Bruker SMART APEXII DUO CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.953, T max = 0.992 10336 measured reflections 2808 independent reflections 1448 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.053 wR(F 2) = 0.183 S = 1.04 2808 reflections 110 parameters H-atom parameters constrained Δρmax = 0.18 e Å−3 Δρmin = −0.14 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536811031928/tk2777sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811031928/tk2777Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811031928/tk2777Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H13NOF(000) = 352
Mr = 163.21Dx = 1.114 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 1653 reflections
a = 5.450 (3) Åθ = 3.8–22.7°
b = 9.698 (6) ŵ = 0.07 mm1
c = 18.455 (12) ÅT = 297 K
β = 93.888 (13)°Needle, colourless
V = 973.1 (11) Å30.67 × 0.15 × 0.12 mm
Z = 4
Bruker SMART APEXII DUO CCD area-detector diffractometer2808 independent reflections
Radiation source: fine-focus sealed tube1448 reflections with I > 2σ(I)
graphiteRint = 0.033
φ and ω scansθmax = 30.0°, θmin = 2.4°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −7→7
Tmin = 0.953, Tmax = 0.992k = −13→13
10336 measured reflectionsl = −18→25
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.053Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.183H-atom parameters constrained
S = 1.04w = 1/[σ2(Fo2) + (0.0833P)2 + 0.063P] where P = (Fo2 + 2Fc2)/3
2808 reflections(Δ/σ)max < 0.001
110 parametersΔρmax = 0.18 e Å3
0 restraintsΔρmin = −0.14 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.0482 (2)0.64909 (13)0.46391 (6)0.0829 (4)
H1O1−0.03820.57640.45640.124*
N10.1886 (2)0.60421 (14)0.52725 (7)0.0663 (4)
C10.8076 (3)0.3977 (2)0.72018 (9)0.0761 (5)
H1A0.81500.34230.67930.091*
C20.9742 (4)0.3766 (3)0.77902 (11)0.0949 (6)
H2A1.08960.30620.77750.114*
C30.9709 (4)0.4577 (3)0.83903 (11)0.0972 (7)
H3A1.08440.44330.87830.117*
C40.8004 (4)0.5602 (3)0.84143 (10)0.0977 (7)
H4A0.79890.61690.88210.117*
C50.6284 (4)0.5800 (2)0.78301 (10)0.0871 (6)
H5A0.51000.64860.78560.104*
C60.6307 (3)0.49911 (17)0.72088 (8)0.0644 (4)
C70.4539 (3)0.52421 (19)0.65522 (9)0.0771 (5)
H7A0.28880.53510.67100.093*
H7B0.45420.44470.62330.093*
C80.5231 (3)0.65179 (17)0.61365 (9)0.0691 (5)
H8A0.52230.73000.64640.083*
H8B0.69040.64040.59970.083*
C90.3630 (3)0.68632 (15)0.54665 (8)0.0621 (4)
C100.4212 (4)0.8158 (2)0.50706 (11)0.0922 (6)
H10D0.40400.79930.45570.138*
H10A0.58700.84350.52070.138*
H10B0.30980.88740.51940.138*
U11U22U33U12U13U23
O10.0914 (9)0.0805 (8)0.0714 (7)−0.0160 (6)−0.0336 (6)0.0219 (6)
N10.0682 (8)0.0669 (8)0.0603 (7)−0.0095 (6)−0.0206 (6)0.0125 (6)
C10.0762 (11)0.0854 (11)0.0650 (10)0.0016 (10)−0.0076 (8)0.0009 (8)
C20.0778 (12)0.1242 (17)0.0802 (12)0.0272 (12)−0.0129 (10)0.0050 (11)
C30.0823 (13)0.1379 (18)0.0681 (11)0.0064 (13)−0.0184 (9)0.0096 (12)
C40.1167 (17)0.1168 (16)0.0582 (10)0.0051 (14)−0.0042 (10)−0.0083 (10)
C50.0883 (13)0.0952 (13)0.0767 (11)0.0192 (11)−0.0007 (10)0.0041 (10)
C60.0567 (9)0.0725 (10)0.0622 (9)−0.0149 (8)−0.0088 (7)0.0149 (7)
C70.0691 (10)0.0795 (11)0.0787 (11)−0.0199 (9)−0.0238 (8)0.0216 (8)
C80.0655 (9)0.0738 (10)0.0654 (9)−0.0189 (8)−0.0160 (8)0.0101 (7)
C90.0658 (9)0.0599 (8)0.0591 (8)−0.0107 (7)−0.0068 (7)0.0047 (6)
C100.1152 (16)0.0778 (12)0.0808 (12)−0.0301 (11)−0.0151 (11)0.0204 (9)
O1—N11.4212 (17)C5—H5A0.9300
O1—H1O10.8540C6—C71.516 (2)
N1—C91.273 (2)C7—C81.517 (2)
C1—C61.378 (3)C7—H7A0.9700
C1—C21.383 (3)C7—H7B0.9700
C1—H1A0.9300C8—C91.502 (2)
C2—C31.360 (3)C8—H8A0.9700
C2—H2A0.9300C8—H8B0.9700
C3—C41.364 (3)C9—C101.497 (2)
C3—H3A0.9300C10—H10D0.9600
C4—C51.393 (3)C10—H10A0.9600
C4—H4A0.9300C10—H10B0.9600
C5—C61.390 (3)
N1—O1—H1O198.1C6—C7—H7A109.3
C9—N1—O1112.95 (12)C8—C7—H7A109.3
C6—C1—C2121.40 (18)C6—C7—H7B109.3
C6—C1—H1A119.3C8—C7—H7B109.3
C2—C1—H1A119.3H7A—C7—H7B108.0
C3—C2—C1120.6 (2)C9—C8—C7116.60 (13)
C3—C2—H2A119.7C9—C8—H8A108.1
C1—C2—H2A119.7C7—C8—H8A108.1
C2—C3—C4119.67 (19)C9—C8—H8B108.1
C2—C3—H3A120.2C7—C8—H8B108.1
C4—C3—H3A120.2H8A—C8—H8B107.3
C3—C4—C5119.97 (19)N1—C9—C10124.47 (15)
C3—C4—H4A120.0N1—C9—C8118.24 (13)
C5—C4—H4A120.0C10—C9—C8117.29 (14)
C6—C5—C4121.15 (19)C9—C10—H10D109.5
C6—C5—H5A119.4C9—C10—H10A109.5
C4—C5—H5A119.4H10D—C10—H10A109.5
C1—C6—C5117.14 (16)C9—C10—H10B109.5
C1—C6—C7120.95 (16)H10D—C10—H10B109.5
C5—C6—C7121.86 (17)H10A—C10—H10B109.5
C6—C7—C8111.64 (13)
C6—C1—C2—C3−1.3 (3)C1—C6—C7—C8−103.8 (2)
C1—C2—C3—C40.5 (3)C5—C6—C7—C873.7 (2)
C2—C3—C4—C51.0 (3)C6—C7—C8—C9179.16 (15)
C3—C4—C5—C6−1.7 (3)O1—N1—C9—C10−1.1 (2)
C2—C1—C6—C50.5 (3)O1—N1—C9—C8179.05 (13)
C2—C1—C6—C7178.14 (17)C7—C8—C9—N1−3.1 (2)
C4—C5—C6—C10.9 (3)C7—C8—C9—C10177.02 (17)
C4—C5—C6—C7−176.64 (17)
D—H···AD—HH···AD···AD—H···A
O1—H1O1···N1i0.851.972.785 (3)160
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O1—H1O1⋯N1i0.851.972.785 (3)160

Symmetry code: (i) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.

Authors:  T H Althuis; P F Moore; H J Hess
Journal:  J Med Chem       Date:  1979-01       Impact factor: 7.446

3.  Synthesis and antitumor activity of some new substituted quinolin-4-one and 1,7-naphthyridin-4-one analogs.

Authors:  H I el-Subbagh; A H Abadi; I E al-Khawad; K A al-Rashood
Journal:  Arch Pharm (Weinheim)       Date:  1999-01       Impact factor: 3.751

4.  Synthesis and antimicrobial and anti-inflammatory activities of substituted 2-mercapto-3-(N-aryl)pyrimido[5,4-c]cinnolin-4-(3H)-ones.

Authors:  L V Nargund; V V Badiger; S M Yarnal
Journal:  J Pharm Sci       Date:  1992-04       Impact factor: 3.534

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.